On the other hand, the enrichment in overtargeted KEGG pathways highlighted miRNA-regulated pathways in cancer, resistance to endocrine therapy, FoxO signaling, PI3K/Akt signaling, and sphingolipid signaling, among others (Figure 3C). Here, AKT1 is linked to cancer.